Startups

Annexon Biosciences

Annexon Biosciences develops therapies targeting C1q and the classical complement pathway for neuroinflammatory diseases affecting the body, brain and eye.

Founded 2011

Team

No team members on record yet.

Investments

$75M2018-12-19	Bain Capital Life Sciences, Adage Capital, Surveyor Capital, NEA, Blackstone Life Sciences, Novartis Venture Fund, Satter Investment Management
$100MUnknown date	Bain Capital, Adage Capital Management, New Enterprise Associates, Logos Capital, Eventide Asset Management, Blackstone Life Sciences